Skip to content
The Policy VaultThe Policy Vault

BronchitolMedical Mutual

Cystic Fibrosis

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Patient has tried hypertonic saline; AND
  • Patient has passed the Bronchitol Tolerance Test; AND
  • Patient will pre-medicate with a short-acting bronchodilator; AND
  • Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
  • Medication is used as add-on maintenance therapy to improve pulmonary function

Reauthorization criteria

  • Patient is age ≥ 18 years; AND
  • Patient has tried hypertonic saline; AND
  • Patient has passed the Bronchitol Tolerance Test; AND
  • Patient will pre-medicate with a short-acting bronchodilator; AND
  • Medication is prescribed by or in consultation with a pulmonologist or a physician who specializes in the treatment of cystic fibrosis; AND
  • Medication is used as add-on maintenance therapy to improve pulmonary function; AND
  • Patient has experienced an adequate response to therapy, as evidenced by improvement in FEV1 and/or other lung function tests per the prescribing physician

Approval duration

365 days